Proteomic analysis of the transitional endoplasmic reticulum in hepatocellular carcinoma: An organelle perspective on cancer

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1804, Issue 9, 2010, Pages 1869-1881

  Roy, Line ^b   LaBoissière, Sylvie ^b   Abdou, Eman ^a   Thibault, Geneviève ^a   Hamel, Nathalie ^b   Taheri, Maryam ^a   Boismenu, Daniel ^b   Lanoix, Joël ^c   Kearney, Robert E ^d   Paiement, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer biomarker; Hepatocellular carcinoma; Quantitative organelle proteomics; Transitional endoplasmic reticulum

Indexed keywords

AFLATOXIN B1; BASIC TRANSCRIPTION FACTOR 3; CALRETICULIN; CYTOCHROME P450; DYNACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE ASSOCIATED PROGESTERONE RECEPTOR COMPONENT 1; MEMBRANE PROTEIN; MYC PROTEIN; NUCLEOLIN; NUCLEOPHOSMIN; PEPTIDE HYDROLASE; PROTEASOME; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PUR BETA; TRIPEPTIDYL PEPTIDASE II; TUMOR MARKER; UBIQUITIN; UNCLASSIFIED DRUG; POISON; PROTEOME;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CELL ISOLATION; CELL ORGANELLE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID METABOLISM; FUNCTIONAL PROTEOMICS; IMMUNOBLOTTING; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN METABOLISM; RAT; RIBOSOME; STEROID METABOLISM; TANDEM MASS SPECTROMETRY; TRANSITIONAL ENDOPLASMIC RETICULUM; TUMOR CELL; ANIMAL; CHEMICALLY INDUCED; ENDOPLASMIC RETICULUM; FISCHER 344 RAT; HUMAN; METABOLISM; TOXICITY; ULTRASTRUCTURE;

RATTUS;

AFLATOXIN B1; ANIMALS; CARCINOMA, HEPATOCELLULAR; ENDOPLASMIC RETICULUM; HUMANS; LIVER NEOPLASMS; MALE; ORGANELLES; POISONS; PROTEOME; RATS; RATS, INBRED F344; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 77955093828     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2010.05.008     Document Type: Article

References (121)

1. Baumann O., Walz B. Endoplasmic reticulum of animal cells and its organization into structural and functional domains. Int. Rev. Cytol. 2001, 205:149-214.
2. Shibata Y., Voeltz G.K., Rapoport T.A. Rough sheets and smooth tubules. Cell 2006, 126:435-439.
3. Lavoie C., Paiement J. Topology of molecular machines of the endoplasmic reticulum: a compilation of proteomics and cytological data. Histochem. Cell Biol. 2008, 129:117-128.
4. Bernales S., Papa F.R., Walter P. Intracellular signaling by the unfolded protein response. Annu. Rev. Cell Dev. Biol. 2006, 22:487-508.
5. Heath-Engel H.M., Chang N.C., Shore G.C. The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family. Oncogene 2008, 27:6419-6433.
6. Stolz A., Wolf D.H. Endoplasmic reticulum associated protein degradation: a chaperone assisted journey to hell. Biochim. Biophys. Acta 2010, 1803:694-705.
7. Healy S.J., Gorman A.M., Mousavi-Shafaei P., Gupta S., Samali A. Targeting the endoplasmic reticulum-stress response as an anticancer strategy. Eur. J. Pharmacol. 2009, 625:234-246.
8. Wlodkowic D., Skommer J., McGuinness D., Hillier C., Darzynkiewicz Z. ER-Golgi network-a future target for anti-cancer therapy. Leuk. Res. 2009, 33:1440-1447.
9. Hoeller D., Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009, 428:438-444.
10. Brunet S., Thibault P., Gagnon E., Kearney P., Bergeron J.J., Desjardins M. Organelle proteomics: looking at less to see more. Trends Cell Biol. 2003, 13:629-638.
11. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94:153-156.
12. Farazi P.A., DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 2006, 6:674-687.
13. Liu Y., Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment, Environ. Health Perspect. 2010, 118:818-824.
14. Fan J.G., Farrell G.C. Asia-Pacific Working Party for Prevention of Hepatocellular Carcinoma, prevention of hepatocellular carcinoma in nonviral-related liver diseases. J. Gastroenterol. Hepatol. 2009, 24:712-719.
15. Butler W.H., Jones G. Ultrastructure of hepatic neoplasia. Rat Hepatic Neoplasia 1978, 142-179. MIT Press, Cambridge. W.H. Butler, P. Newberne (Eds.).
16. Abdou E., Taheri M., Roy L., Thibault G., Boismenu D., Servant F., Kearney R., Paiement J. The proteome of the endoplasmic reticulum in cancer. Mol. Biol. Cell 2006, 17. (suppl), Abst. # 1292.
17. Butler W.H., Greenblatt M., Lijinsky W. Carcinogenesis in rats by aflatoxins B1, G1, and B2. Cancer Res. 1969, 29:2206-2211.
18. Paiement J., Dominguez J.M., Guenette A., Roy L. GTP-dependent membrane fusion during hepatocarcinogenesis and liver regeneration. Biochem. Biophys. Res. Commun. 1991, 176:1494-1500.
19. Lanoix J., Paiement J. Changes in GTP-dependent fusion and ras-related proteins in membranes from rat hepatocellular carcinomas. Cancer Lett. 1995, 98:1-8.
20. Jones G., Butler W.H. Light microscopy of rat hepatic neoplasia. Rat Hepatic Neoplasia 1978, 115-140. MIT Press, Cambridge. W.H. Butler, P. Newberne (Eds.).
21. Paiement J., Young R., Roy L., Bergeron J.J.M. Isolation of rough and smooth membrane domains of the endoplasmic reticulum from rat liver. Cell Biology: A Laboratory Handbook 2006, Vol. 2:41-44. Elsevier Science. 3rd ed. J.E. Celis (Ed.).
22. Roy L., Bergeron J.J., Lavoie C., Hendriks R., Gushue J., Fazel A., Pelletier A., Morre D.J., Subramaniam V.N., Hong W., Paiement J. Role of p97 and syntaxin 5 in the assembly of transitional endoplasmic reticulum. Mol. Biol. Cell 2000, 11:2529-2542.
23. Lavoie C., Lanoix J., Kan F.W., Paiement J. Cell-free assembly of rough and smooth endoplasmic reticulum. J. Cell Sci. 1996, 109:1415-1425.
24. Lavoie C., Paiement J., Dominguez M., Roy L., Dahan S., Gushue J.N., Bergeron J.J. Roles for alpha(2)p24 and COPI in endoplasmic reticulum cargo exit site formation. J. Cell Biol. 1999, 146:285-299.
25. Wasiak S., Legendre-Guillemin V., Puertollano R., Blondeau F., Girard M., de Heuvel E., Boismenu D., Bell A.W., Bonifacino J.S., McPherson P.S. Enthoprotin: a novel clathrin-associated protein identified through subcellular proteomics. J. Cell Biol. 2002, 158:855-862.
26. Kearney R., Blondeau F., McPherson P., Bell A., Servant F., Drapeau M., de Grandpre S., Bergeron J.M. Elimination of redundant protein identifications in high throughput proteomics. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2005, 5:4803-4806.
27. Gilchrist A., Au C.E., Hiding J., Bell A.W., Fernandez-Rodriguez J., Lesimple S., Nagaya H., Roy L., Gosline S.J., Hallett M., Paiement J., Kearney R.E., Nilsson T., Bergeron J.J. Quantitative proteomics analysis of the secretory pathway. Cell 2006, 127:1265-1281.
28. Blondeau F., Ritter B., Allaire P.D., Wasiak S., Girard M., Hussain N.K., Angers A., Legendre-Guillemin V., Roy L., Boismenu D., Kearney R.E., Bell A.W., Bergeron J.J., McPherson P.S. Tandem MS analysis of brain clathrin-coated vesicles reveals their critical involvement in synaptic vesicle recycling. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3833-3838.
29. Liu H., Sadygov R.G., Yates J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76:4193-4201.
30. Rhodes D.R., Kalyana-Sundaram S., Mahavisno V., Varambally R., Yu J., Briggs B.B., Barrette T.R., Anstet M.J., Kincead-Beal C., Kulkarni P., Varambally S., Ghosh D., Chinnaiyan A.M. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007, 9:166-180.
31. Baudhuin P., Evrard P., Berthet J. Electron microscopic examination of subcellular fractions. I. The preparation of representative samples from suspensions of particles. J. Cell Biol. 1967, 32:181-191.
32. Morisseau C., Hammock B.D. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu. Rev. Pharmacol. Toxicol. 2005, 45:311-333.
33. Hayes J.D., Judah D.J., McLellan L.I., Neal G.E. Contribution of the glutathione S-transferases to the mechanisms of resistance to aflatoxin B1. Pharmacol. Ther. 1991, 50:443-472.
34. Kelly V.P., Ellis E.M., Manson M.M., Chanas S.A., Moffat G.J., McLeod R., Judah D.J., Neal G.E., Hayes J.D. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver. Cancer Res. 2000, 60:957-969.
35. Chen X., Cheung S.T., So S., Fan S.T., Barry C., Higgins J., Lai K.M., Ji J., Dudoit S., Ng I.O., Van De Rijn M., Botstein D., Brown P.O. Gene expression patterns in human liver cancers. Mol. Biol. Cell 2002, 13:1929-1939.
36. Osada S., Naganawa A., Misonou M., Tsuchiya S., Tamba S., Okuno Y., Nishikawa J., Satoh K., Imagawa M., Tsujimoto G., Sugimoto Y., Nishihara T. Altered gene expression of transcriptional regulatory factors in tumor marker-positive cells during chemically induced hepatocarcinogenesis. Toxicol. Lett. 2006, 167:106-113.
37. Hu R., Xu C., Shen G., Jain M.R., Khor T.O., Gopalkrishnan A., Lin W., Reddy B., Chan J.Y., Kong A.N. Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray. Life Sci. 2006, 79:1944-1955.
38. Yates M.S., Kwak M.K., Egner P.A., Groopman J.D., Bodreddigari S., Sutter T.R., Baumgartner K.J., Roebuck B.D., Liby K.T., Yore M.M., Honda T., Gribble G.W., Sporn M.B., Kensler T.W. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-, 12-dioxooleana-1, 9(11)-dien-28-oyl]imidazole. Cancer Res. 2006, 66:2488-2494.
39. Zhang H., Kim J.K., Edwards C.A., Xu Z., Taichman R., Wang C.Y. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 2005, 7:909-915.
40. Peluso J.J., Pappalardo A., Losel R., Wehling M. Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action. Endocrinology 2006, 147:3133-3140.
41. Kerr L.E., Birse-Archbold J.L., Short D.M., McGregor A.L., Heron I., Macdonald D.C., Thompson J., Carlson G.J., Kelly J.S., McCulloch J., Sharkey J. Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene 2007, 26:2554-2562.
42. Huai J., Firat E., Nil A., Million D., Gaedicke S., Kanzler B., Freudenberg M., van Endert P., Kohler G., Pahl H.L., Aichele P., Eichmann K., Niedermann G. Activation of cellular death programs associated with immunosenescence-like phenotype in TPPII knockout mice. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5177-5182.
43. Peluso J.J., Liu X., Saunders M.M., Claffey K.P., Phoenix K. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. J. Clin. Endocrinol. Metab. 2008, 93:1592-1599.
44. Kloetzel P.M. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat. Immunol. 2004, 5:661-669.
45. Raposo G., van Santen H.M., Leijendekker R., Geuze H.J., Ploegh H.L. Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment. J. Cell Biol. 1995, 131:1403-1419.
46. Zuber C., Fan J.Y., Guhl B., Roth J. Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice. FASEB J. 2004, 18:917-919.
47. Palmer A., Rivett A.J., Thomson S., Hendil K.B., Butcher G.W., Fuertes G., Knecht E. Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol. Biochem. J. 1996, 316:401-407.
48. Villar J., Quadri H.S., Song I., Tomita Y., Tirado O.M., Notario V. PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization. Cancer Res. 2009, 69:102-110.
49. Németh J., Stein I., Haag D., Riehl A., Longerich T., Horwitz E., Breuhahn K., Gebhardt C., Schirmacher P., Hahn M., Ben-Neriah Y., Pikarsky E., Angel P., Hess J. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 2009, 50:1251-1262.
50. Gerke V., Creutz C.E., Moss S.E. Annexins: linking Ca2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 2005, 6:449-461.
51. Faure A.V., Migne C., Devilliers G., Ayala-Sanmartin J. Annexin 2 "secretion" accompanying exocytosis of chromaffin cells: possible mechanisms of annexin release. Exp. Cell Res. 2002, 276:79-89.
52. Farhan H., Hauri H.P. Membrane biogenesis: networking at the ER with atlastin. Curr. Biol. 2009, 13:R906-R908.
53. Markiewski M.M., Lambris J.D. Unwelcome complement. Cancer Res. 2009, 69:6367-6370.
54. Gurkan C., Stagg S.M., Lapointe P., Balch W.E. The COPII cage: unifying principles of vesicle coat assembly. Nat. Rev. Mol. Cell Biol. 2006, 7:727-738.
55. Presley J.F., Cole N.B., Schroer T.A., Hirschberg K., Zaal K.J., Lippincott-Schwartz J. ER-to-Golgi transport visualized in living cells. Nature 1997, 389:81-85.
56. Watson P., Forster R., Palmer K.J., Pepperkok R., Stephens D.J. Coupling of ER exit to microtubules through direct interaction of COPII with dynactin. Nat. Cell Biol. 2005, 7:48-55.
57. Yamasaki A., Tani K., Yamamoto A., Kitamura N., Komada M. The Ca2+-binding protein ALG-2 is recruited to endoplasmic reticulum exit sites by Sec31A and stabilizes the localization of Sec31A. Mol. Biol. Cell 2006, 17:4876-4887.
58. Shimoi W., Ezawa I., Nakamoto K., Uesaki S., Gabreski G., Aridor M., Yamamoto A., Nagahama M., Tagaya M., Tani K. p125 is localized in endoplasmic reticulum exit sites and involved in their organization. J. Biol. Chem. 2005, 280:10141-10148.
59. Cohen M., Stutz F., Belgareh N., Haguenauer-Tsapis R., Dargemont C. Ubp3 requires a cofactor, Bre5, to specifically de-ubiquitinate the COPII protein, Sec23. Nat. Cell Biol. 2003, 5:661-667.
60. Soncini C., Berdo I., Draetta G. Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease. Oncogene 2001, 20:3869-3879.
61. Linn T.C., Srere P.A. Binding of ATP citrate lyase to the microsomal fraction of rat liver. J. Biol. Chem. 1984, 259:13379-13384.
62. Swinnen J.V., Brusselmans K., Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9:358-365.
63. Boren J., Ramos-Montoya A., Bosch K.S., Vreeling H., Jonker A., Centelles J.J., Cascante M., Frederiks W.M. In situ localization of transketolase activity in epithelial cells of different rat tissues and subcellularly in liver parenchymal cells. J. Histochem. Cytochem. 2006, 54:191-199.
64. Frederiks W.M., Vreeling-Sindelarova H. Localization of glucose-6-phosphate dehydrogenase activity on ribosomes of granular endoplasmic reticulum, in peroxisomes and peripheral cytoplasm of rat liver parenchymal cells. Histochem. J. 2001, 33:345-353.
65. Benlimame N., Le P.U., Nabi I.R. Localization of autocrine motility factor receptor to caveolae and clathrin-independent internalization of its ligand to smooth endoplasmic reticulum. Mol. Biol. Cell 1998, 9:1773-1786.
66. Tsutsumi S., Hogan V., Nabi I.R., Raz A. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res. 2003, 63:242-249.
67. Funasaka T., Hu H., Hogan V., Raz A. Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence. J. Biol. Chem. 2007, 282:36362-36369.
68. Bola B., Allan V. How and why does the endoplasmic reticulum move?. Biochem. Soc. Trans. 2009, 37:961-965.
69. Zou L., Jaramillo M., Whaley D., Wells A., Panchapakesa V., Das T., Roy P. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br. J. Cancer 2007, 97:1361-1371.
70. Shi Y., Wang H.C., Yin Y.H., Sun W.S., Li Y., Zhang C.Q., Wang Y., Wang S., Chen W.F. Identification and analysis of tumour-associated antigens in hepatocellular carcinoma. Br. J. Cancer 2005, 92:929-934.
71. Klopfenstein D.R., Kappeler F., Hauri H.P. A novel direct interaction of endoplasmic reticulum with microtubules. EMBO J. 1998, 17:6168-6177.
72. Farah C.A., Liazoghli D., Perreault S., Desjardins M., Guimont A., Anton A., Lauzon M., Kreibich G., Paiement J., Leclerc N. Interaction of microtubule-associated protein-2 and p63: a new link between microtubules and rough endoplasmic reticulum membranes in neurons. J. Biol. Chem. 2005, 280:9439-9449.
73. Dreyfuss G., Kim V., Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 2002, 3:195-205.
74. Sun W., Xing B., Sun Y., Du X., Lu M., Hao C., Lu Z., Mi W., Wu S., Wei H., Gao X., Zhu Y., Jiang Y., Qian X., He F. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol. Cell. Proteomics 2007, 6:1798-1808.
75. Visa N., Alzhanova-Ericsson A.T., Sun X., Kiseleva E., Bjorkroth B., Wurtz T., Daneholt B. A pre-mRNA-binding protein accompanies the RNA from the gene through the nuclear pores and into polysomes. Cell 1996, 84:253-264.
76. Maggi L.B., Kuchenruether M., Dadey D.Y., Schwope R.M., Grisendi S., Townsend R.R., Pandolfi P.P., Weber J.D. Nucleophosmin serves as a rate-limiting nuclear export chaperone for the mammalian ribosome. Mol. Cell. Biol. 2008, 28:7050-7065.
77. Holz M.K., Ballif B.A., Gygi S.P., Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 2005, 123:569-580.
78. Liu X., Zheng X.F. Endoplasmic reticulum and Golgi localization sequences for mammalian target of rapamycin. Mol. Biol. Cell 2007, 18:1073-1082.
79. Guertin D.A., Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 2007, 12:9-22.
80. Lavoie C., Chevet E., Roy L., Tonks N.K., Fazel A., Posner B., Paiement J., Bergeron J.J. Tyrosine phosphorylation of p97 regulates transitional endoplasmic reticulum assembly in vitro. Proc. Natl. Acad. Sci. U.S. A. 2000, 97:13637-13642.
81. Lin S.S., Bassik M.C., Suh H., Nishino M., Arroyo J.D., Hahn W.C., Korsmeyer S.J., Roberts T.M. PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum. J. Biol. Chem. 2006, 281:23003-23012.
82. Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.M., Polakiewicz R.D., Comb M.J. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 2005, 23:94-101.
83. Messias A.C., Harnisch C., Ostareck-Lederer A., Sattler M., Ostareck D.H. The DICE-binding activity of KH domain 3 of hnRNP K is affected by c-Src-mediated tyrosine phosphorylation. J. Mol. Biol. 2006, 361:470-481.
84. Pan S., World C.J., Kovacs C.J., Berk B.C. Glucose 6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2009, 29:895-901.
85. Yamauchi T., Keough R.A., Gonda T.J., Ishii S. Ribosomal stress induces processing of Mybbp1a and its translocation from the nucleolus to the nucleoplasm. Genes Cells 2008, 13:27-39.
86. Foster L.V., de Hoog C.L., Zhang Y., Zhang Y., Xie X., Mootha V.K., Mann M. A mammalian organelle map by protein correlation profiling. Cell 2006, 125:187-199.
87. Menssen A., Hermeking H. Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6274-6279.
88. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
89. Swanson H.I., Njar V.C., Yu Z., Castro D.J., Gonzalez F.J., Williams D.E., Huang Y., Kong A.N., Doloff J.C., Ma J., Waxman D.J., Scott E.E. Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy. Drug Metab. Dispos. 2010, 38:539-544.
90. Baer B.R., Rettie A.E. CYP4B1: an enigmatic P450 at the interface between xenobiotic and endobiotic metabolism. Drug Metab. Rev. 2006, 38:451-476.
91. Meissonnier G.M., Laffitte J., Loiseau N., Benoit E., Raymond I., Pinton P., Cossalter A.M., Bertin G., Oswald I.P., Galtier P. Selective impairment of drug-metabolizing enzymes in pig liver during subchronic dietary exposure to aflatoxin B1. Food Chem. Toxicol. 2007, 45:2145-2154.
92. Fradette C., Du Souich P. Effect of hypoxia on cytochrome P450 activity and expression. Curr. Drug Metab. 2004, 5:257-271.
93. Pan C., Kumar C., Bohl S., Klingmueller U., Mann M. Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type specific functions. Mol. Cell. Proteomics 2008, 8:443-450.
94. Hoskins J.M., Carey L.A., McLeod H.L. CYP2D6 and tamoxifen: DNA matters in breast cancer. Nat. Rev. Cancer 2009, 9:576-586.
95. Bruno R.D., Njar V.C. Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg. Med. Chem. 2007, 15:5047-5060.
96. Izumi T., Yamaguchi M. Overexpression of regucalcin suppresses cell death in cloned rat hepatoma H4-II-E cells induced by tumor necrosis factor-alpha or thapsigargin. J. Cell. Biochem. 2004, 92:296-306.
97. Monteith G.R., McAndrew D., Faddy H.M., Roberts-Thomson S.J. Calcium and cancer: targeting Ca (2+) transport. Nat. Rev. Cancer 2007, 7:519-530.
98. Kuhajda F.P. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 2006, 66:5977-5980.
99. Rossi S., Graner E., Febbo P., Weinstein L., Bhattacharya N., Onody T., Bubley G., Balk S., Loda M. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol. Cancer Res. 2003, 1:707-715.
100. Vihko P., Harkonen P., Soronen P., Torn S., Herrala A., Kurkela R., Pulkka A., Oduwole O., Isomaa V. 17 beta-hydroxysteroid dehydrogenases-their role in pathophysiology. Mol. Cell. Endocrinol. 2004, 215:83-88.
101. Geuze H.J., Murk J.L., Stroobants A.K., Griffith J.M., Kleijmeer M.J., Koster A.J., Verkleij A.J., Distel B., Tabak H.F. Involvement of the endoplasmic reticulum in peroxisome formation. Mol. Biol. Cell 2003, 14:2900-2907.
102. Leclercq S., Skrzypski J., Courvoisier A., Gondcaille C., Bonnetain F., André A., Chardigny J.M., Bellenger S., Bellenger J., Narce M., Savary S. Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters. Biochimie 2008, 90:1602-1607.
103. Bi M., Naczki C., Koritzinsky M., Fels D., Blais J., Hu N., Harding H., Novoa I., Varia M., Raleigh J., Scheuner D., Kaufman R.J., Bell J., Ron D., Wouters B.G., Koumenis C. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 2005, 24:3470-3481.
104. Moenner M., Pluquet O., Bouchecareilh M., Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res. 2007, 67:10631-10634.
105. Su R., Li Z., Li H., Song H., Bao C., Wei J., Cheng L. Grp78 promotes the invasion of hepatocellular carcinoma. B.M.C. Cancer 2010, 19. 10:20.
106. Gumireddy K., Sun F., Klein-Szanto A.J., Gibbins J.M., Gimotty P.A., Saunders A.J., Schultz P.G., Huang Q. In vivo selection for metastasis promoting genes in the mouse. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6696-6701.
107. So A.Y., de la Fuente E., Walter P., Shuman M., Bernales S. The unfolded protein response during prostate cancer development. Cancer Metastasis Rev. 2009, 28:219-223.
108. Tsukumo Y., Tomida A., Kitahara O., Nakamura Y., Asada S., Mori K., Tsuruo T. Nucleobindin 1 controls the unfolded protein response by inhibiting ATF6 activation. J. Biol. Chem. 2007, 282:29264-29272.
109. Hammer G.E., Kanaseki T., Shastri N. The final touches make perfect the Peptide-MHC Class I repertoire. Immunity 2007, 26:397-406.
110. Raffaghello L., Prigione I., Bocca P., Morandi F., Camoriano M., Gambini C., Wang X., Ferrone S., Pistoia V. Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications. Oncogene 2005, 24:4634-4644.
111. Romero J.M., Jimenez P., Cabrera T., Cozar J.M., Pedrinaci S., Tallada M., Garrido F., Ruiz-Cabello F. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Int. J. Cancer 2005, 113:605-610.
112. Giorda E., Sibilio L., Martayan A., Moretti S., Venturo I., Mottolese M., Ferrara G.B., Cappellacci S., Eibenschutz L., Catricala C., Grammatico P., Giacomini P. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells. Cancer Res. 2003, 63:4119-4127.
113. Krishnakumar S., Sundaram A., Abhyankar D., Krishnamurthy V., Shanmugam M.P., Gopal L., Sharma T., Biswas J. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma. Cancer 2004, 100:1059-1069.
114. Bendtsen J.D., Nielsen H., von Heijne G., Brunak S. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 2004, 340:783-795.
115. Sonnhammer E.L., von Heijne G., Krogh A. A hidden Markov model for predicting transmembrane helices in protein sequences. Proc. Int. Conf. Intell. Syst. Mol. Biol. 1998, 6:175-182.
116. Puntervoll P., Linding R., Gemund C., Chabanis-Davidson S., Mattingsdal M., Cameron S., Martin D.M., Ausiello G., Brannetti B., Costantini A., Ferre F., Maselli V., Via A., Cesareni G., Diella F., Superti-Furga G., Wyrwicz L., Ramu C., McGuigan C., Gudavalli R., Letunic I., Bork P., Rychlewski L., Kuster B., Helmer-Citterich M., Hunter W.N., Aasland R., Gibson T.J. ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res. 2003, 31:3625-3630.
117. Zahedi R.P., Völzing C., Schmitt A., Frien M., Jung M., Dudek J., Wortelkamp S., Sickmann A., Zimmermann R. Analysis of the membrane proteome of canine pancreatic rough microsomes identifies a novel Hsp40, termed ERj7. Proteomics 2009, 9:3463-3473.
118. Poderycki M.J., Kickhoefer V.A., Kaddis C.S., Raval-Fernandes S., Johansson E., Zink J.I., Loo J.A., Rome L.H. The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior. Biochemistry 2006, 45:12184-12193.
119. Kedersha N.L., Rome L.H. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J. Cell Biol. 1986, 103:699-709.
120. Lee N.P., Chen L., Lin M.C., Tsang F.H., Yeung C., Poon R.T., Peng J., Leng X., Beretta L., Sun S., Day P.J., Luk J.M. Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. J. Proteome Res. 2009, 8:1293-1303.
121. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482.